RMC Advisory committees

In addition to the advisory committees below (the HQP Program Advisory Committee and the KTEE Advisory Committee), the RMC also receives input from the Executive Committee of the NMIN HQP Network (NHN).

HQP Program Advisory Committee

The HQP Program Advisory Committee (HPAC) is an advisory standing committee reporting to the Research Management Committee (RMC) of NMIN. The HPAC has up to 10 members.

The mandate of the HPAC is to advise RMC on training and programming opportunities that will increase the knowledge, skills and expertise of trainees and new professionals in the field of nanomedicine.

CHAIR: Nicolas Bertrand

Associate Professor, Université Laval

Ildiko Badea

Professor, College of Pharmacy and Nutrition University of Saskatchewan

Devika Chithrani

Associate Professor, Department of Physics & Astronomy, University of Victoria

Michael Doschak

Professor, Pharmacy & Pharmaceutical Sciences, University of Alberta

CHAIR: Don Enns

Vice President and Head of Global Drug Delivery, Evonik Industries

Helen Burt

Associate Vice-President Research & Innovation, UBC

Christine Charette

Managing Director, Scientia Advisors & Investments

Marianna Foldvari

Professor of Pharmaceutical Sciences, University of Waterloo

Emmanuel Ho

Associate Professor, School of Pharmacy & Dept. of Chemical Engineering, University of Waterloo

Andrew R. Martin

Associate Professor, Mechanical Engineering, University of Alberta

Naomi Matsuura

Associate Professor, Materials Science & Engineering, University of Toronto

Donald Miller

Professor, Department of Pharmacology & Therapeutics, University of Manitoba

Michael Coughtrie

Professor and Dean, Faculty of Pharmaceutical Sciences, UBC

Pieter Cullis

Scientific Director & CEO, NMIN

Lesley Esford

Director, Innovate BC

Rebecca Yu

Vice President, Market Access and External Affairs, Takeda Canada

Michael List

Partner, GreenSky Capital

Norma Sebestyen

Ex-Director of Policy and Patient Access, Merck